Keybanc cut the price target for Baxter International Inc. (NYSE: BAX) from $53 to $51. Keybanc analyst Matthew Mishan maintained an Overweight rating. Baxter International shares rose 1.2% to $47.58 in pre-market trading.
U.S. stocks traded higher, with the Nasdaq Composite gaining around 200 points on Friday. Here are some big stocks recording gains in today’s session.
Reata Pharmaceuticals, Inc. (NASDAQ: RETA) rose 53.3% to $166.41 after Biogen agreed to acquire the company.
2023 Outlook Update
We have more than typical of our second half sales outlook already booked in backlog and given the synergy achievement to date, the continued demand in our commercial pipeline of
Today Chart Industries, Inc. (NYSE:GTLS) ("Chart"), a leading global engineering design and manufacturer of highly engineered equipment servicing multiple applications in the clean energy and industrial gas